Quality of Life Comparison in Patients With Different Types of Alopecia
NCT04246957 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2020-12-02
Summary
Hair loss is a frequent cause of patient consultation in dermatology. It is known to have a strong impact on patients' quality of life for many reasons; such as esthetic aspect, financial implications, social consequences. Numerous studies have assessed the impact of some types of alopecia on patients' quality of life. One study compared the quality of life in patients with scarring alopecia with patients of non-scarring alopecia. No studies have compared quality of life between the different types of scarring alopecia nor different types of non-scarring alopecia. However, none have assessed the impact on the patient partner quality of life. In addition, few treatments for alopecia are covered by national health insurance in France. The main objective is to compare the impact on the quality of life in different types of alopecia. By using the average scores of the questionnaire Dermatology Life Quality Index (DLQI) for each type of alopecia.
Conditions
- Alopecia
- Quality of Life
Interventions
- BEHAVIORAL
-
general quality of life questionary
Every patient will have to fill out a general quality of life questionary : DLQI (Dermatology Life Quality Index)
- BEHAVIORAL
-
specific quality of life questionary
Every patient will have to fill out a specific quality of life questionary : Hair Specific Skindex 29.
Sponsors & Collaborators
-
Centre Hospitalier Universitaire, Amiens
lead OTHER
Principal Investigators
-
Catherine LOK, Pr · CHU Amiens
-
Thomas Baltazard, MD · CHU Amiens
-
Nesrine Zitouni, MD · CHU Amiens
-
Fanny Dessirier, MD · CHU Amiens
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-03-04
- Primary Completion
- 2020-11-16
- Completion
- 2020-11-16
Countries
- France
Study Locations
More Related Trials
-
Evaluation of the Efficacy and Tolerability of Treatment With Interleukin-2 in Severe and Resistant Alopecia Areata
NCT01840046 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Barriers to Care and QOL for CCCA Patients
NCT03044782 ·Status: COMPLETED
-
Benefits of a Cosmetic Anti-hair Loss in Males With Hair Loss
NCT06590779 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
The Epidemiology, Management and Comorbidities in Alopecia Areata in Czech Republic
NCT05098600 ·Status: COMPLETED
-
Efficacy of Combined Microneedling With Methotrexate in Treatment of Alopecia Areata
NCT05485571 ·Status: UNKNOWN ·Phase: NA
-
Ocular Finding in Alopecia Areata
NCT03155958 ·Status: UNKNOWN
-
A Randomised Control Trial of Integrative Cognitive Behavioural Therapy for Alopecia
NCT04205214 ·Status: COMPLETED ·Phase: NA
-
Comparative Study Examining the Effectiveness in Use of a DERMOJET and a Normal Syringe Treatment for Patients With Hair Loss - Alopecia Areata
NCT01017510 ·Status: UNKNOWN ·Phase: NA
-
PAI-1 Expression in Non-scarring Hair Loss
NCT02548689 ·Status: TERMINATED
-
Assessment of Biological and Biometrological Parameters in Adult Subjects with Androgenetic Alopecia
NCT06854432 ·Status: TERMINATED ·Phase: NA
-
Prevention of Alopecia in Patients With Localised Breast Cancer
NCT06011525 ·Status: RECRUITING ·Phase: NA
-
Pilot Study of the Safety and Efficacy of Apremilast in Subjects With Moderate to Severe Alopecia Areata
NCT02684123 ·Status: COMPLETED ·Phase: NA
-
The Effectiveness of Mindfulness Based Cognitive Group Therapy for Social Anxiety Symptoms in People Living With Alopecia Areata
NCT03873155 ·Status: COMPLETED ·Phase: NA
-
Study to Determine Effect of Gentle Wounding to Stimulate Hair Follicle Neogenesis
NCT03491267 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
A Study to Evaluate Efficacy and Safety of Deucravacitinib in Participants With Alopecia Areata
NCT05556265 ·Status: TERMINATED ·Phase: PHASE2
-
Characterization and Risk Factors of Folliculitis After Hair Transplantation
NCT05793164 ·Status: COMPLETED
-
Evaluation of Serum Levels of Interlukin-15 and Interlukin-21 in Patients With Alopecia Areata
NCT05910138 ·Status: UNKNOWN ·Phase: NA
-
EValuation of the Impact of a TOpical Lotion on Permanent Chemotherapy Induced Hair Disorders in Cancer Survivors
NCT02605629 ·Status: COMPLETED ·Phase: NA
-
Clinical Trial of Safety and Efficacy of Daily Application of Topical Dutasteride in Men With Androgenic Alopecia.
NCT05599243 ·Status: COMPLETED ·Phase: PHASE2
-
1565nm Non-ablative Fractional Laser Treat Alopecia Areata
NCT05744505 ·Status: UNKNOWN ·Phase: NA
-
Comparison of Microneedling Along With Topical Vitamin D3 Versus Microneedling in Alopecia Areata
NCT07243977 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Topical Simvastatin Versus Topical Steroid in Treatment of Alopecia Areata
NCT06399783 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
The Epidemiology, Management, and the Associated Burden of Related Conditions in Alopecia Areata
NCT04239521 ·Status: COMPLETED
-
Cryotherapy Versus Steroids In Alopecia Areata:Trichoscopic Evaluation
NCT03473600 ·Status: UNKNOWN ·Phase: PHASE4
-
Evaluation of the Effect of Topical Calcipotriol Versus Platelet-Rich Plasma
NCT05954104 ·Status: COMPLETED ·Phase: NA